AGPYY yields 124.22% · JNJ yields 2.13%● Live data
📍 AGPYY pulled ahead of the other in Year 1
Combined, AGPYY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AGPYY + JNJ for your $10,000?
Agile Group Holdings Limited, an investment holding company, engages in the property development, property management, hotel operation, property investment, environmental protection, and other businesses in the People's Republic of China. As of December 31, 2021, the company had a land bank with a total gross floor area of 47.37 million square meters in 84 cities located in Southern China region, Eastern China region, Western China region, Central China region, Hainan and Yunnan region, Northeast China region, Northern China region, Hong Kong, and internationally. It also provides property management services, as well as residential property management, asset management, public property management, civil services, and community business. In addition, the company provides operation of ecological industrial park, hazardous waste treatment, and daily waste treatment to commercial food waste treatment; and sludge treatment, soil treatment, and water restoration to sewage treatment, and water affairs. The company was formerly known as Agile Property Holdings Limited and changed its name to Agile Group Holdings Limited in July 2016. The company was incorporated in 2005 and is headquartered in Guangzhou, the People's Republic of China. Agile Group Holdings Limited is a subsidiary of Top Coast Investment Limited.
Full AGPYY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.